Search Results - "de Fabregues, Oriol"

The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study) by Pont-Sunyer, Claustre, Hotter, Anna, Gaig, Carles, Seppi, Klaus, Compta, Yaroslau, Katzenschlager, Regina, Mas, Natalia, Hofeneder, Dominik, Brücke, Thomas, Bayés, Angels, Wenzel, Karoline, Infante, Jon, Zach, Heidemarie, Pirker, Walter, Posada, Ignacio J., Álvarez, Ramiro, Ispierto, Lourdes, De Fàbregues, Oriol, Callén, Antoni, Palasí, Antoni, Aguilar, Miquel, Martí, Maria José, Valldeoriola, Francesc, Salamero, Manel, Poewe, Werner, Tolosa, Eduardo

“…ABSTRACT Nonmotor symptoms (NMS) in Parkinson's disease (PD) can precede onset of motor symptoms. Relationship between premotor symptoms onset and motor…”
Get full text

Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers by Pont-Sunyer, Claustre, Iranzo, Alex, Gaig, Carles, Fernández-Arcos, Ana, Vilas, Dolores, Valldeoriola, Francesc, Compta, Yaroslau, Fernández-Santiago, Ruben, Fernández, Manel, Bayés, Angels, Calopa, Matilde, Casquero, Pilar, de Fàbregues, Oriol, Jaumà, Serge, Puente, Victor, Salamero, Manel, José Martí, Maria, Santamaría, Joan, Tolosa, Eduard

“…In idiopathic Parkinson disease (IPD) sleep disorders are common and may antedate the onset of parkinsonism. Based on the clinical similarities between IPD and…”
Get full text

Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson’s disease and examination of its possible etiologies: infectious or autoimmune? by de Fàbregues, Oriol, Sellés, Maria, Ramos-Vicente, David, Roch, Gerard, Vila, Miquel, Bové, Jordi

“…Tissue-resident memory CD8 T cells are responsible for local immune surveillance in different tissues, including the brain. They constitute the first line of…”
Get full text

Pleuropulmonary Toxicity of Another Anti-Parkinson's Drug: Cabergoline by Belmonte, Yolanda, de Fàbregues, Oriol, Marti, Marta, Domingo, Christian

“…Many drugs may cause toxic injury to the lungs and the pleura. Cabergoline is an ergoline derivative which has been used in Spain for seven years to control…”
Get full text

Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study by Compta, Yaroslau, Dias, Sara P., Giraldo, Darly M., Pérez-Soriano, Alexandra, Muñoz, Esteban, Saura, Josep, Fernández, Manel, Bravo, Paloma, Cámara, Ana, Pulido-Salgado, Marta, Painous, Cèlia, Ríos, José, Martí, María José, Pagonabarraga, Javier, Valldeoriola, Francesc, Hernández-Vara, Jorge, Classen, Serge Jauma, Puente, Victor, Pont, Claustre, Caballol, Núria, Tolosa, Eduardo, Bayes, Angels, Campdelacreu, Jaume, de Fàbregues, Oriol, Ávila, Asunción, Calopa, Matilde, Gaig, Carles, Fabregat, Neus, Pastor, Pau, Aguilar, Miquel, Pujol, Montserrat, Sánchez, Almudena, Planellas, Lluís, Ezquerra, Mario, Fernández-Santiago, Rubén, Botta, Teresa, Tartaglia, Gian

“…Neuroinflammation is a potential player in neurodegenerative conditions, particularly the aggressive ones, such as multiple system atrophy (MSA). Previous…”
Get full text

Discovering the 3' UTR-mediated regulation of alpha-synuclein by Marchese, Domenica, Botta-Orfila, Teresa, Cirillo, Davide, Rodriguez, Juan Antonio, Livi, Carmen Maria, Fernández-Santiago, Rubén, Ezquerra, Mario, Martí, Maria J, Bechara, Elias, Tartaglia, Gian Gaetano

“…Recent evidence indicates a link between Parkinson's Disease (PD) and the expression of a-synuclein (SNCA) isoforms with different 3' untranslated regions…”
Get full text

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series by De Fabregues, Oriol, Viñas, Jaume, Palasí, Antoni, Quintana, Manuel, Cardona, Ignasi, Auger, Cristina, Vargas, Víctor

“…Objectives To present our experience with ammonium tetrathiomolybdate (ATTM) in the decoppering phase treatment of Wilson's disease (WD) with neurological…”
Get full text

An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients by Krüger, Rejko, Lingor, Paul, Doskas, Triantafyllos, Henselmans, Johanna M. L., Danielsen, Erik H., de Fabregues, Oriol, Stefani, Alessandro, Sensken, Sven-Christian, Parra, Juan Carlos, Onuk, Koray, Yegin, Ashley, Antonini, Angelo

“…Introduction Continuous delivery of levodopa–carbidopa intestinal gel (LCIG) by percutaneous endoscopic gastrojejunostomy (PEG-J) in advanced Parkinson’s…”
Get full text

Long‐term safety and effectiveness of levodopa‐carbidopa intestinal gel infusion by De Fabregues, Oriol, Dot, Joan, Abu‐Suboh, Monder, Hernández‐Vara, Jorge, Ferré, Alex, Romero, Odile, Ibarria, Marta, Seoane, José Luis, Raguer, Nuria, Puiggros, Carolina, Gómez, Maria Rosa, Quintana, Manuel, Armengol, Josep Ramon, Alvarez‐Sabín, José

“…Introduction Levodopa‐carbidopa intestinal gel (LCIG) infusion has demonstrated to improve motor fluctuations. The aim of this study is to assess the long‐term…”
Get full text

Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson’s Disease: A Pilot Study by Quintana, Manuel, Romero, Odile, Ferré, Alex, De Fabregues, Oriol, Álvarez-Sabin, José

“…Background. Sleep problems in patients with advanced Parkinson’s disease (PD) have a deleterious impact on quality of life. Objective. To assess the effect of…”
Get full text

Subclinical affective and cognitive fluctuations in Parkinson's disease: a randomized double-blind double-dummy study of Oral vs. Intrajejunal Levodopa by Kulisevsky, Jaime, Bejr-Kasem, Helena, Martinez-Horta, Saul, Horta-Barba, Andrea, Pascual-Sedano, Berta, Campolongo, Antonia, Marín-Lahoz, Juan, Aracil-Bolaños, Ignacio, Pérez-Pérez, Jesús, Izquierdo-Barrionuevo, Cristina, de Fàbregues, Oriol, Puente, Victor, Crespo-Cuevas, Ane, Calopa, Matilde, Pagonabarraga, Javier

“…Background Chronic levodopa treatment in Parkinson’s disease (PD) may promote undesirable motor and non-motor fluctuations. Compared to chronic oral levodopa…”
Get full text

Transcriptomic differences in MSA clinical variants by Pérez-Soriano, Alexandra, Arnal Segura, Magdalena, Botta-Orfila, Teresa, Giraldo, Darly, Fernández, Manel, Compta, Yaroslau, Fernández-Santiago, Rubén, Ezquerra, Mario, Tartaglia, Gian G., Martí, M. J.

“…Background: Multiple system atrophy (MSA) is a rare oligodendroglial synucleinopathy of unknown etiopathogenesis including two major clinical variants with…”
Get full text

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry by Antonini, Angelo, Poewe, Werner, Chaudhuri, K. Ray, Jech, Robert, Pickut, Barbara, Pirtošek, Zvezdan, Szasz, Jozsef, Valldeoriola, Francesc, Winkler, Christian, Bergmann, Lars, Yegin, Ashley, Onuk, Koray, Barch, David, Odin, Per, Amalia, Ene, Arnold, Guy, Bajenaru, Ovidiu, Bergmans, Bruno, Bjornara, Kari Anne, Blackie, Jeff, Bode, Matthias, Bourgeois, Paul, Bohlhalter, Stephan, Buraga, Ioan, Burkhard, Pierre R., Busson, Philippe, Calopa, Matilde, Clausen, Jesper, Danielsen, Erik Hvid, Defebvre, Luc, Delvaux, Valerie, Dethy, Sophie, Dietrichs, Espen, De Fabregues, Oriol, Gerhard, Ransmayr, Gusmaroli, Graziano, Hahn, Kirsten, Hauptmann, Björn, Henriksen, Tove, Hernandez-Vara, Jorge, Jeanjean, A., Kaiserova, Michaela, Kassubek, Jan, Kimber, Thomas, Konitsiotis, Spyridon, Krüger, Rejko, Kulisevsky, Jaime, Leenders, Jo, Lundqvist, Christofer, Ory Magne, F., Marano, Pietro, Milanov, Ivan, Modugno, Nicola, Misbahuddin, Anjum, Nevrly, Martin, Panayiotis, Zikos, Pedersen, Kenn Freddy, Pedersen, Stephen W., Perju-Dumbrava, Lacramioara, Ponsen, M.M., Popescu, Bogdan O., Rijntjes, Michel, Puente, V., Redecker, Christoph, Schrader, Christoph, Sensi, Mariachiara, Simu, Mihaela, Spanaki, Cleanthe, Storch, Alexander, Storstein, Anette, Tomantschger, Volker, van der Linden, Chris, van Laar, T., Viallet, F., Witjas, Tatiana, Wolz, Martin, Zibetti, Maurizio, Van Zandijcke, Michel

“…This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients…”
Get full text

Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence? by Catalán, Maria José, Antonini, Angelo, Calopa, Matilde, Băjenaru, Ovidiu, de Fábregues, Oriol, Mínguez-Castellanos, Adolfo, Odin, Per, García-Moreno, José Manuel, Pedersen, Stephen W., Pirtošek, Zvezdan, Kulisevsky, Jaime

“…Advanced Parkinson's disease (APD) is characterized by increased functional disability, caused by motor complications, the presence of axial symptoms, and…”
Get full text

α‐synuclein RT‐QuIC in cerebrospinal fluid of LRRK2‐linked Parkinson's disease by Garrido, Alicia, Fairfoul, Graham, Tolosa, Eduardo S., Martí, Maria José, Green, Alison

“…Background Leucine‐rich kinase 2 (LRRK2)‐linked Parkinson's disease (PD) is clinically indistinguishable from idiopathic PD (IPD). A pleiotropic neuropathology…”
Get full text

Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease by Sampedro, Frederic, Martínez-Horta, Saul, Horta-Barba, Andrea, Grothe, Michel J., Labrador-Espinosa, Miguel A., Jesús, Silvia, Adarmes-Gómez, Astrid, Carrillo, Fátima, Puig-Davi, Arnau, Lora, Florinda Roldán, Barberá, Miquel Aguilar, Pastor, Pau, Arroyo, Sonia Escalante, Vila, Berta Solano, Foraster, Anna Cots, Martínez, Javier Ruiz, Padilla, Francisco Carrillo, Morlans, Mercedes Pueyo, Aramburu, Isabel González, Ceberio, Jon Infante, Vara, Jorge Hernández, de Fábregues-Boixar, Oriol, de Deus Fonticoba, Teresa, Ávila, Asunción, Martínez-Castrillo, Juan Carlos, Bejr-Kasem, Helena, Campolongo, Antonia, Pascual-Sedano, Berta, Martínez-Martín, Pablo, Santos-García, Diego, Mir, Pablo, Kulisevsky, Jaime

“…Blood homocysteine appears to be increased in Parkinson's disease (PD) and may play a role in the development and progression of this disorder. However, the…”
Get full text

Effects of COVID -19 pandemic and lockdown on people with multiple system atrophy participating in a therapeutic education program by Cámara, Ana, Compta, Yaroslau, Pérez-Soriano, Alexandra, Montagut, Núria, Baixauli, Montserrat, Maragall, Laura, Ludeña, Emma, Lopez de los Reyes, Juan Carlos, Peri-Cusi, Lluís, Fernández, Noemí, Villote, Susana, Ahuir, Maribel, Grau, Anna, Caballol, Núria, Buongiorno, Mariateresa, Pont-Sunyer, Claustre, Puente, Víctor, Giraldo, Darly M., de Fabregues, Oriol, Garrido, Alícia, Navarro-Otano, Judith, Painous, Cèlia, Sánchez-Gómez, Almudena, Muñoz, Esteban, Zaro, Idoia, Obiang, Donina, Valldeoriola, Francesc, Lombraña, María, Martí, María-José

Get full text

In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study by Grothe, Michel J., Labrador-Espinosa, Miguel A., Jesús, Silvia, Macías-García, Daniel, Adarmes-Gómez, Astrid, Carrillo, Fátima, Camacho, Elena Iglesias, Franco-Rosado, Pablo, Lora, Florinda Roldán, Martín-Rodríguez, Juan Francisco, Barberá, Miquel Aguilar, Pastor, Pau, Arroyo, Sonia Escalante, Vila, Berta Solano, Foraster, Anna Cots, Martínez, Javier Ruiz, Padilla, Francisco Carrillo, Morlans, Mercedes Pueyo, Aramburu, Isabel González, Ceberio, Jon Infante, Vara, Jorge Hernández, de Fábregues-Boixar, Oriol, de Deus Fonticoba, Teresa, Pascual-Sedano, Berta, Kulisevsky, Jaime, Martínez-Martín, Pablo, Santos-García, Diego, Mir, Pablo

“…We aimed to assess associations between multimodal neuroimaging measures of cholinergic basal forebrain (CBF) integrity and cognition in Parkinson's disease…”
Get full text

Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome by Vanegas, Maria I., Marcé-Grau, Anna, Martí-Sánchez, Laura, Mellid, Sara, Baide-Mairena, Heidy, Correa-Vela, Marta, Cazurro, Anna, Rodríguez, Carla, Toledo, Laura, Fernández-Ramos, Joaquín Alejandro, Pons, Roser, Aguilera-Albesa, Sergio, Martí, Maria José, Eiris, Jesús, Iglesias, Gema, De Fabregues, Oriol, Maqueda, Elena, Garriz-Luis, Maite, Madruga, Marcos, Espinós, Carmen, Macaya, Alfons, Cabrera, José Carlos, Pérez-Dueñas, Belén

“…To perform phenotype and genotype characterization in myoclonus-dystonia patients and to validate clinical rating tools. Two movement disorders experts rated…”
Get full text

Smoking is associated with age at disease onset in Parkinson's disease by Rosas, Irene, Morís, Germán, Coto, Eliecer, Blázquez-Estrada, Marta, Suárez, Esther, García-Fernández, Ciara, Martínez, Carmen, Herrera, Israel Duarte, Pérez-Oliveira, Sergio, Álvarez, Victoria, Menéndez-González, Manuel, Adarmes-Gómez, Astrid D., Aguilar, Miquel, Alvarez, Ignacio, Barrero, Francisco Javier, Bergareche Yarza, Jesús Alberto, Bonilla-Toribio, Marta, Botía, Juan A., Boungiorno, María Teresa, Buiza-Rueda, Dolores, Cámara, Ana, Carrillo, Fátima, Cerdan, Debora, Clarimón, Jordi, Compta, Yaroslau, Diez-Fairen, Monica, Dols-Icardo, Oriol, de Fabregues, Oriol, Cartagena, Pilar Sanz, Duarte, Jacinto, Duran, Raquel, Escamilla-Sevilla, Francisco, Ezquerra, Mario, Feliz, Cici, Fernández-Santiago, Rubén, Fernández, Manel, García-Ruiz, Pedro, Gómez-Garre, Pilar, Gomez Heredia, Maria Jose, Gonzalez-Aramburu, Isabel, Gorostidi, Ana, Hoenicka, Janet, Infante, Jon, Jesús, Silvia, Jimenez-Escrig, Adriano, Kulisevsky, Jaime, Labrador-Espinosa, Miguel A., Lopez-Sendon, Jose Luis, López de Munain, Adolfo, Macias-Garcia, Daniel, Martínez-Torres, Irene, Marín, Juan, Marti, Maria Jose, Martínez-Castrillo, Juan Carlos, Álvarez-Santullano, Marina Mata, Mínguez-Castellanos, Adolfo, Mir, Pablo, Rezola, Elisabet Mondragon, Muñoz, Esteban, Pagonabarraga, Javier, Pastor, Pau, Errazquin, Francisco Perez, Periñán, Maria Teresa, Ruiz-Martínez, Javier, Ruz, Clara, Rodriguez, Antonio Sanchez, Sierra, María, Tabernero, Cesar, Tartari, Juan Pablo, Tolosa, Eduard, Valldeoriola, Francesc, Vela, Lydia, Vives, Francisco, Pascual-Sedano, Berta, Hernández-Vara, Jorge, Rolán, Dolores Vilas, Bandrés-Ciga, Sara

“…Previous studies linked disease-progression variables such as age at onset or survival to both genetic, and non-genetic factors in Parkinson's disease (PD)…”
Get full text